chlorthalidone and lisinopril

chlorthalidone has been researched along with lisinopril in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.11)	18.7374
1990's	1 (1.11)	18.2507
2000's	50 (55.56)	29.6817
2010's	34 (37.78)	24.3611
2020's	4 (4.44)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Van Schaik, BA	1
de Leeuw, PW; Notter, T; Zilles, P	1
Einecke, D	1
Schillaci, G; Verdecchia, P	1
Düsing, R	2
Nilsson, P	1
Berglund, G; Håkansson, J; Hernborg, A; Werkö, L	1
Traynor, K	1
Wepner, U	1
Vidt, DG	1
Vetter, W	1
Slany, J	1
Rollins, G	1
Scott, I; Stowasser, M	1
Siragy, HM	1
Messerli, FH; Weber, MA	1
Almajano Domínguez, RM; Cassinello Ogea, C; Girón Nombiela, JA; Izquierdo Villarroya, B; Oro Fraile, J; Ruiz Tramazaygues, J; Sánchez Tirado, JA	1
Ferdinand, KC	1
Rahn, KH	1
Fuchs, FD	1
Kuwajima, I	1
Leenen, FH	1
Cushman, WC; Cutler, JA; Davis, BR; Dunn, JK; Ford, CE; Habib, GB; Haywood, LJ; Leenen, FH; Margolis, KL; Papademetriou, V; Probstfield, JL; Whelton, PK; Wright, JT	1
Barzilay, J; Batuman, V; Davis, BR; Eckfeldt, JH; Farber, M; Henriquez, M; Kopyt, N; Louis, GT; Nwachuku, C; Pressel, S; Rahman, M; Saklayen, M; Stanford, C; Walworth, C; Ward, H; Whelton, PK; Wiegmann, T; Wright, JT	1
Arnett, DK; Black, H; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Miller, MB	2
Barzilay, J; Cushman, WC; Davis, BR; Iiamathi, E; Kostis, JB; Leenen, FH; Louis, GT; Margolis, KL; Mathis, DE; Moloo, J; Nwachuku, C; Panebianco, D; Parish, DC; Pressel, S; Simmons, DL; Thadani, U; Whelton, PK	1
Barzilay, J; Batuman, V; Davis, BR; Eckfeldt, JH; Farber, MA; Franklin, S; Henriquez, M; Kopyt, N; Louis, GT; Nwachuku, C; Pressel, S; Rahman, M; Saklayen, M; Stanford, C; Walworth, C; Ward, H; Whelton, PK; Wiegmann, T; Wright, JT	1
Hollenberg, NK	1
Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M	1
Black, HR; Davis, BR; Ford, CE; Nwachuku, C; Oparil, S; Piller, LB; Probstfield, JL; Retta, TM	1
Karotsis, AK; Mastorantonakis, SE; Stergiou, GS; Symeonidis, A	1
Barzilay, JI; Basile, J; Cutler, JA; Davis, BR; Margolis, KL; Ong, ST; Pressel, SL; Sadler, LS; Summerson, J; Whelton, PK	1
Scarpello, JH; Tahrani, AA; Varughese, GI	1
Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT	1
Baimbridge, C; Barzilay, J; Basile, J; Black, HR; Dart, RA; Davis, B; Marginean, H; Nwachuku, C; Thadani, U; Whelton, P; Wong, ND; Wright, JT	1
Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI	3
Baimbridge, C; Bareis, CJ; Barzilay, J; Basile, JN; Black, HR; Dart, R; Davis, BR; Einhorn, PT; Gupta, AK; Hamilton, BP; Harris-Haywood, S; Haywood, LJ; Jafri, SZ; Louis, GT; Pressel, S; Scott, CL; Simmons, DL; Stanford, C; Whelton, PK; Wright, JT	1
Cutler, JA; Davis, BR; Furberg, CD; Goldman, L; Heidenreich, PA; Lairson, DR; Nwachuku, C; Pressel, SL; Shlipak, MG	1
Basile, JN; Bastien, A; Courtney, DL; Cushman, WC; Davis, BR; Einhorn, PT; Ford, CE; Hamilton, BP; Kirchner, K; Louis, GT; Preston, RA; Retta, TM; Vidt, DG; Weiss, RJ; Whelton, PK; Wright, JT	1
Arnett, DK; Barzilay, JI; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Irvin, MR; Kabagambe, EK; Lynch, AI; Tiwari, HK	1
Alderman, MH; Calhoun, DA; Cushman, WC; Davis, BR; Eckfeldt, JH; Einhorn, PT; Ford, CE; Franklin, SS; Furberg, CD; Ong, ST; Oparil, S; Papademetriou, V; Piller, LB; Probstfield, JL	1
Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI; Zhang, X	1
Baimbridge, C; Barzilay, JI; Brown, CD; Colon, PJ; Cutler, JA; Davis, BR; Fine, LJ; Ford, CE; Grimm, RH; Gupta, AK; Haywood, LJ; Henriquez, MA; Ilamaythi, E; Oparil, S; Piller, LB; Preston, R; Rahman, M; Whelton, PK; Wright, JT	1
Sowers, JR; Whaley-Connell, A	1
Alderman, MH; Blumenthal, SS; Castaldo, RS; Cushman, WC; Cutler, JA; Davis, BR; Ford, CE; Franklin, SS; Furberg, CD; Gordon, D; Graumlich, JF; Pavlik, V; Preston, RA; Proschan, M	1
Cushman, WC; Davis, BR; Ford, CE; Furberg, CD; Habib, GB; Haywood, LJ; Margolis, K; Oparil, S; Probstfield, JL; Whelton, PK; Wright, JT	1
Alderman, MH; Davis, BR; Einhorn, PT; Ford, CE; Furberg, CD; Grimm, RH; Jafri, SZ; Oparil, S; Phillips, W; Piller, LB; Probstfield, JL; Whittle, J; Williamson, JD	1
Jeffers, BW; Wang, JG; Yan, P	1
Davis, BR; Kostis, JB; Levitan, EB; Lynch, AI; Muntner, P; Oparil, S; Simpson, LM; Whelton, PK; Whittle, J	1
Barzilay, JI; Dart, RA; Davis, BR; Einhorn, PT; Graves, JW; Pressel, SL; Reisin, E; Retta, TM; Saklayen, MG; Yamal, JM	1
Baraniuk, S; Basile, JN; Dart, RA; Davis, BR; Ellsworth, AJ; Fendley, H; Habib, GB; Piller, LB; Probstfield, JL; Rahman, M; Simpson, LM; Whelton, PK	1
Beutler, D; Bosak, A; Graeme, K; Heise, CW; Loli, A; Orme, G	1
Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Irvin, MR; Sørensen, IF; Sørensen, P; Vazquez, AI	1
Alderman, MH; Calhoun, DA; Cushman, WC; Davis, BR; Fendley, HF; Franklin, SS; Habib, GB; Oparil, S; Pressel, SL; Probstfield, JL; Sastrasinh, S; Yamal, JM	1
Davis, BR; Lynch, AI; Muntner, P; Oparil, S; Rahman, M; Simpson, LM; Tanner, RM; Whelton, PK; Whittle, J	1
Albert, CM; Alonso, A; Davis, BR; Dewland, TA; Haywood, LJ; Magnani, JW; Marcus, GM; Piller, LB; Soliman, EZ; Yamal, JM	1
Beard, BL; Davis, BR; Ford, CE; Hamilton, BP; Marginean, H; Probstfield, JL; Suhan, PS; Whittle, J; Williamson, JD; Yamal, JM	1
Barzilay, JI; Cushman, WC; Davis, BR; Einhorn, PT; Ghosh, A; Louis, GT; Margolis, KL; Oparil, S; Pressel, SL; Puttnam, R; Whelton, PK; Williamson, J	1
Cushman, WC; Davis, BR; Einhorn, PT; Ernst, ME; Ghosh, A; Grimm, RH; Okin, PM; Oparil, S; Prineas, RJ; Soliman, EZ	1
Bangalore, S; Black, HR; Calhoun, DA; Cushman, WC; Davis, BR; Kostis, JB; Muntner, PM; Pressel, SL; Probstfield, JL; Rahman, M; Whelton, PK	1
Bang, CN; Davis, BR; Devereux, RB; Okin, PM; Simpson, LM; Soliman, EZ	1
Coifman, RR; Coppi, AC; Davis, BR; Dhruva, SS; Furberg, CD; Huang, C; Krumholz, HM; Li, SX; Lin, H; Pressel, SL; Spatz, ES; Warner, F; Xu, X	1
Albert, CM; Alonso, A; Davis, BR; Dewland, TA; Haywood, LJ; Marcus, GM; Simpson, LM; Soliman, EZ; Yamal, JM	1
Cheriyan, J; Chowienczyk, PJ; Cockcroft, JR; Collier, D; Coulson, JM; Dasgupta, I; Faconti, L; Glover, M; Heagerty, AM; Khong, TK; Lip, GYH; Mander, AP; Marchong, MN; Martin, U; McDonnell, BJ; McEniery, CM; Mukhtar, O; Padmanabhan, S; Saxena, M; Sever, PJ; Shiel, JI; Wilkinson, IB; Wych, J	1
Davis, BR; Einhorn, PT; Ford, CE; Ghosh, A; Haywood, LJ; Piller, LB; Probstfield, JL; Simpson, LM; Soliman, EZ; Wright, JT	1
Arnett, DK; Barzilay, JI; Davis, BR; Lai, D; Pressel, S; Previn, HE	1
Devereux, RB; Kjeldsen, SE; Okin, PM	1
Davis, BR; Johnson, K; Oparil, S; Tereshchenko, LG	1
Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Shmerling, RH; Simpson, LM	1
Chang, TI; Itoga, NK; Montez-Rath, ME; Tawfik, DS	1
Bettencourt, JL; Davis, BR; Du, XL; Simpson, LM; Tandy, BC	1
Gongal, P; Hanna, JM; Nanna, MG; Onuma, OK; Wang, SY	1

Reviews

6 review(s) available for chlorthalidone and lisinopril

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Recommendations for the management of special populations: racial and ethnic populations. American journal of hypertension, 2003, Volume: 16, Issue:11 Pt 2 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Ramipril; Randomized Controlled Trials as Topic	2003
[Recent intervention studies with antihypertensive drugs and their influence on guidelines]. Medizinische Klinik (Munich, Germany : 1983), 2003, Dec-15, Volume: 98, Issue:12 Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Clinical Trials as Topic; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Stroke; Time Factors	2003
Diuretics: drugs of choice for the initial management of patients with hypertension. Expert review of cardiovascular therapy, 2003, Volume: 1, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Hypolipidemic Agents; Lisinopril; Randomized Controlled Trials as Topic	2003
[ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Humans; Hypertension; Lisinopril; Male; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Stroke	2004
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials. Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:5 Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic	2014

Trials

45 trial(s) available for chlorthalidone and lisinopril

Article	Year
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study. Journal of hypertension, 1997, Volume: 15, Issue:1 Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Safety; Verapamil	1997
[ALLHAT Study: doxazosin arm is discontinued. Alpha blocker is less effective than a diuretic]. MMW Fortschritte der Medizin, 2000, Mar-30, Volume: 142, Issue:13 Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chlorthalidone; Coronary Disease; Diuretics; Doxazosin; Humans; Hypertension; Lisinopril; Treatment Outcome	2000
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA, 2000, Apr-19, Volume: 283, Issue:15 Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Survival Analysis	2000
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 2002, Dec-18, Volume: 288, Issue:23 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Treatment Outcome	2002
The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure. Cleveland Clinic journal of medicine, 2003, Volume: 70, Issue:3 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure Determination; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Doxazosin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Patient Compliance; Probability; Risk Assessment; Severity of Illness Index; Treatment Outcome	2003
Are thiazide diuretics preferred as first-line therapy for hypertension? An appraisal of The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Internal medicine journal, 2003, Volume: 33, Issue:7 Topics: Aged; Amlodipine; Benzothiadiazines; Blood Chemical Analysis; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Myocardial Infarction; Queensland; Reference Values; Risk Assessment; Severity of Illness Index; Sodium Chloride Symporter Inhibitors; Stroke; Survival Analysis; Treatment Outcome	2003
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Current hypertension reports, 2003, Volume: 5, Issue:4 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male	2003
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Archives of internal medicine, 2005, Apr-25, Volume: 165, Issue:8 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Incidence; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Patient Compliance; Risk Factors; Treatment Outcome	2005
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Circulation, 2005, Jun-28, Volume: 111, Issue:25 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Double-Blind Method; Doxazosin; Female; Follow-Up Studies; Genotype; Humans; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Treatment Outcome	2005
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Archives of internal medicine, 2005, Jun-27, Volume: 165, Issue:12 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Glucose; Chlorthalidone; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypoglycemia; Lisinopril; Male; Middle Aged; Treatment Outcome	2005
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Annals of internal medicine, 2006, Feb-07, Volume: 144, Issue:3 Topics: Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Chronic Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Risk Factors	2006
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation, 2006, May-09, Volume: 113, Issue:18 Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome	2006
Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study. The pharmacogenomics journal, 2007, Volume: 7, Issue:2 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calmodulin-Binding Proteins; Chlorthalidone; Coronary Disease; Double-Blind Method; Doxazosin; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Hypertension; Incidence; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Patient Selection; Polymorphism, Genetic; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Tryptophan	2007
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of clinical hypertension (Greenwich, Conn.), 2006, Volume: 8, Issue:9 Topics: Aged; Aged, 80 and over; Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Canada; Cardiovascular Diseases; Chlorthalidone; Female; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Prognosis; Risk Factors; Time Factors; United States	2006
Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring. Clinical and experimental hypertension (New York, N.Y. : 1993), 2006, Volume: 28, Issue:7 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chlorthalidone; Diltiazem; Drug Therapy, Combination; Felodipine; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Office Visits; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome; Valine; Valsartan	2006
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHA Archives of internal medicine, 2006, Nov-13, Volume: 166, Issue:20 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Chi-Square Distribution; Chlorthalidone; Diabetes Mellitus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Sodium Chloride Symporter Inhibitors; Treatment Outcome	2006
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5 Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People	2007
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Archives of internal medicine, 2008, Jan-28, Volume: 168, Issue:2 Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Black People; Chlorthalidone; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; White People	2008
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of general internal medicine, 2008, Volume: 23, Issue:5 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Cost-Benefit Analysis; Diuretics; Female; Humans; Hypertension; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Myocardial Infarction; Quality-Adjusted Life Years	2008
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of clinical hypertension (Greenwich, Conn.), 2008, Volume: 10, Issue:10 Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Logistic Models; Male; Middle Aged; Treatment Outcome	2008
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study. Pharmacogenetics and genomics, 2009, Volume: 19, Issue:6 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Fibrinogen; Genetic Variation; Genotype; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Middle Aged; Stroke; Treatment Outcome	2009
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study. Journal of hypertension, 2010, Volume: 28, Issue:10 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Chlorthalidone; Diabetes Mellitus; Diuretics; Double-Blind Method; Epithelial Sodium Channels; Fasting; Female; Humans; Hypertension; Lisinopril; Longitudinal Studies; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Retrospective Studies; Risk Factors; Treatment Outcome	2010
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. Pharmacogenetics and genomics, 2012, Volume: 22, Issue:5 Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Coronary Disease; Doxazosin; Female; Follow-Up Studies; Genetic Association Studies; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Proportional Hazards Models; Risk Factors; Treatment Outcome	2012
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:5 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Chemical Analysis; Cardiovascular Diseases; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperkalemia; Hypertension; Hypokalemia; Incidence; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Risk Assessment; Survival Rate; Treatment Outcome	2012
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study. PloS one, 2012, Volume: 7, Issue:3 Topics: Aged; Alleles; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Double-Blind Method; Female; Follow-Up Studies; Genotype; Heart Failure; Humans; Hypertension; Lisinopril; Male; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Risk Factors; Stroke	2012
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR. Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:6 Topics: Amlodipine; Antihypertensive Agents; Canada; Chlorthalidone; Chronic Disease; Coronary Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Hypolipidemic Agents; Incidence; Kaplan-Meier Estimate; Kidney; Kidney Diseases; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Puerto Rico; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Time Factors; Treatment Outcome; United States; United States Virgin Islands	2012
Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension (Dallas, Tex. : 1979), 2013, Volume: 61, Issue:5 Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypolipidemic Agents; Incidence; Lisinopril; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors; Stroke	2013
Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT. Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:11 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Diuretics; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Risk Factors; Treatment Outcome	2013
Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Journal of clinical hypertension (Greenwich, Conn.), 2014, Volume: 16, Issue:5 Topics: Acute Coronary Syndrome; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Chlorthalidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Office Visits; Prognosis; Risk Factors; Treatment Outcome	2014
Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT. Journal of hypertension, 2014, Volume: 32, Issue:7 Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Cohort Studies; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Obesity; Overweight; Prospective Studies	2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. Journal of general internal medicine, 2014, Volume: 29, Issue:11 Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Peripheral Arterial Disease; United States	2014
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:11 Topics: Age Factors; Aged; Amlodipine; Cause of Death; Chlorthalidone; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Sex Factors; Stroke; Survival Rate; Treatment Outcome	2014
Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease. JAMA internal medicine, 2016, 08-01, Volume: 176, Issue:8 Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Electrocardiography; Female; Heart Conduction System; Humans; Lisinopril; Male; Middle Aged; Prognosis	2016
Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trial. BMC health services research, 2016, 07-08, Volume: 16 Topics: Aged; Amlodipine; Antihypertensive Agents; Appointments and Schedules; Black People; Chlorthalidone; Demography; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Medication Adherence; Middle Aged; Myocardial Infarction; North America; Patient Compliance; Retrospective Studies; Treatment Outcome	2016
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial. JAMA internal medicine, 2017, Jan-01, Volume: 177, Issue:1 Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Female; Follow-Up Studies; Hip Fractures; Humans; Intention to Treat Analysis; Lisinopril; Male; Pelvic Bones; Risk Assessment; Risk Factors; United States	2017
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Journal of the American Society of Hypertension : JASH, 2016, Volume: 10, Issue:12 Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypolipidemic Agents; Incidence; Lipids; Lisinopril; Male; Middle Aged; Myocardial Infarction; Prevalence; Risk Factors	2016
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT. The American journal of medicine, 2017, Volume: 130, Issue:4 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Treatment Failure; Treatment Outcome	2017
Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study. American journal of hypertension, 2017, Sep-01, Volume: 30, Issue:9 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cause of Death; Chlorthalidone; Disease Progression; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling	2017
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Hypertension (Dallas, Tex. : 1979), 2017, Volume: 70, Issue:1 Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Doxazosin; Drug Monitoring; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Treatment Outcome	2017
Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Circulation. Arrhythmia and electrophysiology, 2017, Volume: 10, Issue:12 Topics: Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Atrial Flutter; Chlorthalidone; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Primary Prevention; Risk Factors; Time Factors; Treatment Outcome; United States	2017
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYp American heart journal, 2018, Volume: 204 Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Asian People; Black People; Chlorthalidone; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Lisinopril; Middle Aged; Prospective Studies; United Kingdom; White People; Young Adult	2018
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT. Journal of the National Medical Association, 2018, Volume: 110, Issue:4 Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Atrial Flutter; Chlorthalidone; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Hypertension; Lisinopril; Male; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke	2018
The Interaction of a Diabetes Gene Risk Score With 3 Different Antihypertensive Medications for Incident Glucose-level Elevation. American journal of hypertension, 2019, 03-16, Volume: 32, Issue:4 Topics: Alkadienes; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Calcium Channel Blockers; Chlorthalidone; Diabetes Mellitus; Female; Gene Frequency; Genetic Testing; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Sodium Chloride Symporter Inhibitors	2019
Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study. Journal of the American Heart Association, 2019, 04-16, Volume: 8, Issue:8 Topics: Aged; Amlodipine; Antihypertensive Agents; Causality; Chlorthalidone; Doxazosin; Electrocardiography; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Linear Models; Lisinopril; Logistic Models; Male; Middle Aged; Personal Protective Equipment; Proportional Hazards Models	2019
Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker. PloS one, 2021, Volume: 16, Issue:11 Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Risk Factors; United States	2021

Other Studies

39 other study(ies) available for chlorthalidone and lisinopril

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Angiotensin converting enzyme inhibitors and diuretics in hypertension. Pharmaceutisch weekblad. Scientific edition, 1987, Aug-21, Volume: 9, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Chlorthalidone; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Lisinopril	1987
[Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:9 Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Canada; Chlorthalidone; Coronary Disease; Diuretics; Doxazosin; Humans; Hypertension; Lisinopril; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; United States	2000
[Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial]. Deutsche medizinische Wochenschrift (1946), 2003, Jan-31, Volume: 128, Issue:5 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Research Design; Treatment Outcome	2003
[ALLHAT--the most comprehensive antihypertensive treatment trial in the world. The significance of thiazide diuretics for patients older than 55 years is confirmed]. Lakartidningen, 2003, Feb-06, Volume: 100, Issue:6 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Sodium Chloride Symporter Inhibitors	2003
[Consequences of ALLHAT: Thiazides rehabilitated--time to change prescription patterns]. Lakartidningen, 2003, Feb-06, Volume: 100, Issue:6 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Cost Savings; Diuretics; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors	2003
ALLHAT finds diuretics best for initial hypertension therapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Feb-01, Volume: 60, Issue:3 Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Clinical Trials as Topic; Diuretics; Humans; Hypertension; Lisinopril; Myocardial Infarction	2003
Diuretics: first choice for treating high BP. Health news (Waltham, Mass.), 2003, Volume: 9, Issue:2 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Middle Aged	2003
[Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!]. MMW Fortschritte der Medizin, 2003, Jan-16, Volume: 145, Issue:1-2 Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Humans; Hypertension; Lisinopril; Middle Aged; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors	2003
Hats off to an old blood pressure drug. For treating high blood pressure, an old--and inexpensive--medication is a great place to start or a good one to add. Harvard heart letter : from Harvard Medical School, 2003, Volume: 13, Issue:7 Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Clinical Trials as Topic; Diuretics; Humans; Hypertension; Lisinopril	2003
[What are the sequelae of the ALLHAT Study?]. Deutsche medizinische Wochenschrift (1946), 2003, Mar-28, Volume: 128, Issue:13 Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Critical Pathways; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic	2003
Diuretics: older, cheaper, better. The Johns Hopkins medical letter health after 50, 2003, Volume: 15, Issue:2 Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Doxazosin; Humans; Hypertension; Lisinopril; Middle Aged; Sodium Chloride Symporter Inhibitors	2003
[ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug]. Wiener klinische Wochenschrift, 2003, Mar-31, Volume: 115, Issue:5-6 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cause of Death; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Long-Term Care; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2003
Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors. Report on medical guidelines & outcomes research, 2003, Jan-24, Volume: 14, Issue:2 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; United States	2003
A cheaper way to control high blood pressure. Harvard health letter, 2003, Volume: 28, Issue:5 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Diuretics; Humans; Hypertension; Lisinopril	2003
ALLHAT--all hit or all miss? Key questions still remain. The American journal of cardiology, 2003, Aug-01, Volume: 92, Issue:3 Topics: Amlodipine; Antihypertensive Agents; Black People; Chlorthalidone; Humans; Hypolipidemic Agents; Lisinopril; Myocardial Infarction; Research Design; Survival Analysis; White People	2003
[The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure]. MMW Fortschritte der Medizin, 2003, Volume: 145 Suppl 1 Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Doxazosin; Follow-Up Studies; Heart Failure; Humans; Lisinopril; Middle Aged; Myocardial Infarction; Primary Prevention; Stroke; Time Factors	2003
[Severe perioperative hypotension after nephrectomy with adrenalectomy]. Revista espanola de anestesiologia y reanimacion, 2002, Volume: 49, Issue:4 Topics: Addison Disease; Adrenalectomy; Adrenocorticotropic Hormone; Aged; Angiotensin-Converting Enzyme Inhibitors; Anuria; Chlorthalidone; Diagnosis, Differential; Diuretics; Female; Humans; Hydrocortisone; Hypertension; Hypothalamo-Hypophyseal System; Lisinopril; Nephrectomy; Obesity; Pituitary-Adrenal System; Pyelonephritis	2002
ALLHAT: what has it taught us so far? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Sep-28, Volume: 171, Issue:7 Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Humans; Hypertension; Lisinopril; Myocardial Infarction; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic	2004
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA, 2005, Apr-06, Volume: 293, Issue:13 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Humans; Hypertension; Lisinopril; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Summaries for patients. Do the effects of blood pressure drugs differ by kidney function? Annals of internal medicine, 2006, Feb-07, Volume: 144, Issue:3 Topics: Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Chronic Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Risk Factors	2006
Omission of drug dose information. Archives of internal medicine, 2006, Feb-13, Volume: 166, Issue:3 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Dose-Response Relationship, Drug; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic	2006
Blood pressure drugs can boost blood sugar. Depending on the drug, though, it may not matter. Harvard heart letter : from Harvard Medical School, 2007, Volume: 17, Issue:6 Topics: Amlodipine; Antihypertensive Agents; Blood Glucose; Chlorthalidone; Clinical Trials as Topic; Diabetes Mellitus; Diuretics; Humans; Lisinopril	2007
The putative link between glycemic control and cardiac arrhythmias. Archives of internal medicine, 2007, Jul-09, Volume: 167, Issue:13 Topics: Amlodipine; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Glucose; Chlorthalidone; Diabetes Mellitus; Diuretics; Humans; Hypertension; Lisinopril	2007
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Diabetes care, 2008, Volume: 31, Issue:2 Topics: Aged; Amlodipine; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Chlorthalidone; Cohort Studies; Coronary Disease; Female; Humans; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Risk Factors	2008
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA, 2008, Jan-23, Volume: 299, Issue:3 Topics: Aged; Amlodipine; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Diuretics; Doxazosin; Female; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide	2008
Strengthening diuretics' role in hypertension. Managed care (Langhorne, Pa.), 2010, Volume: 19, Issue:9 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Humans; Hypertension; Lisinopril	2010
Initial choice of antihypertensive on long-term cardiovascular outcomes in CKD. Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:6 Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypolipidemic Agents; Kidney; Kidney Diseases; Lisinopril; Male; Myocardial Infarction	2012
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? Statistics in medicine, 2013, Feb-28, Volume: 32, Issue:5 Topics: Amlodipine; Antihypertensive Agents; Biostatistics; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Coronary Disease; Endpoint Determination; Heart Failure; Humans; Hypertension; Lisinopril; Myocardial Infarction; Randomized Controlled Trials as Topic; Regression Analysis; Treatment Outcome	2013
Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2015, Volume: 11, Issue:1 Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Atenolol; Cardiovascular Agents; Chlorthalidone; Combined Modality Therapy; Decontamination; Drug Overdose; Emergency Service, Hospital; Endoscopy, Digestive System; Extracorporeal Membrane Oxygenation; Female; Humans; Lisinopril; Multiple Organ Failure; Renal Dialysis; Shock, Cardiogenic; Tablets; Transcutaneous Electric Nerve Stimulation; Treatment Outcome	2015
Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study. Pharmacogenetics and genomics, 2014, Volume: 24, Issue:11 Topics: Aged; Amlodipine; Chlorthalidone; Female; Genotype; Humans; Lisinopril; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Stroke	2014
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT. Clinical journal of the American Society of Nephrology : CJASN, 2016, Mar-07, Volume: 11, Issue:3 Topics: Aged; Amlodipine; Antihyperkalemic Agents; Blood Pressure; Blood Pressure Determination; Chlorthalidone; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome	2016
Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients. Journal of hypertension, 2019, Volume: 37, Issue:3 Topics: Antihypertensive Agents; Bundle-Branch Block; Chlorthalidone; Electrocardiography; Heart Conduction System; Humans; Hypertension; Lisinopril	2019
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Journal of hypertension, 2020, Volume: 38, Issue:5 Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Gout; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Treatment Outcome	2020
Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study. Journal of the American College of Cardiology, 2021, 10-26, Volume: 78, Issue:17 Topics: Aged; Amlodipine; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Chlorthalidone; Diastole; Female; Follow-Up Studies; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Risk Assessment; Risk Factors; Stroke; Systole	2021
Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial. American heart journal, 2022, Volume: 254 Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Humans; Hypertension; Isolated Systolic Hypertension; Lisinopril; Treatment Outcome	2022